Palouse Capital Management’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.2K Hold
1,315
0.06% 99
2026
Q1
$90.6K Buy
1,315
+302
+30% +$23.6K 0.06% 95
2025
Q4
$89.3K Sell
1,013
-63
-6% -$5.36K 0.06% 95
2025
Q3
$89.6K Buy
1,076
+232
+27% +$20.2K 0.06% 99
2025
Q2
$78.9K Hold
844
0.05% 99
2025
Q1
$89.2K Hold
844
0.06% 96
2024
Q4
$81.6K Hold
844
0.05% 105
2024
Q3
$83.4K Sell
844
-1,342
-61% -$123K 0.05% 104
2024
Q2
$188K Sell
2,186
-124
-5% -$9.75K 0.13% 67
2024
Q1
$175K Buy
+2,310
New +$178K 0.12% 76

Other funds holding MMSI

Palouse Capital Management's MMSI Position: Q2 2026 in Review

Palouse Capital Management held its Merit Medical Systems (MMSI) position steady in Q2 2026 at 1,315 shares worth $91.2K. The position accounts for 0.06% of the portfolio, ranked #99.

Palouse Capital Management first reported a position in MMSI in Q1 2024 and has held it in 10 quarters since. The position peaked at $188K in Q2 2024. 181 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Palouse Capital Management held 1,315 shares of Merit Medical Systems worth $91.2K as of Q2 2026.
  • Palouse Capital Management left its Merit Medical Systems share count unchanged in Q2 2026.
  • Merit Medical Systems made up 0.06% of Palouse Capital Management's portfolio in Q2 2026, its #99 holding.
  • Palouse Capital Management first reported a position in Merit Medical Systems in Q1 2024 and has held it in 10 quarters since.
  • Palouse Capital Management's Merit Medical Systems position peaked at $188K in Q2 2024.
  • 181 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Palouse Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.